Amyloid angiopathy and variability in amyloid β deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease

American Journal of Pathology

Volumn 158, Issue 6, 2001, Pages 2165-2175

  Mann, David M A ^a   Pickering Brown, Stuart M ^a   Takeuchi, Ayano ^b   Iwatsubo, Takeshi ^b   Arango, Juan ^c   Bird, Tom ^c   Van Broeckhoven, Christine ^c   Brooks, William ^c   Brown, Rosemary ^c   Cairns, Nigel ^c   Cras, Patrick ^c   Ellison, David ^c   Haltia, Matti ^c   Ii, Kunio ^c   Jorgensen, Arne ^c   Krill, Jillian ^c   Lantos, Peter ^c   Lippa, Carol ^c   Martins, Ralph ^c   Nochlin, David ^c   Pollen, Daniel ^c   Rosenberg, Carlyn ^c   Rossor, Martin ^c   Tabira, Takeshi ^c   more..

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF TOKYO   (Japan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; BETA CATENIN; GAMMA SECRETASE; PRESENILIN 1;

ADULT; ALLELE; ALZHEIMER DISEASE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; GENE FUNCTION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PLAQUE FORMING CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; VASCULAR AMYLOIDOSIS;

EID: 0034975365     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64688-3     Document Type: Article

References (66)

1. Biology of presenilins as causative molecules for Alzheimer's disease
2. The cell biology of beta-amyloid precursor protein and presenilins in Alzheimer's disease
3. Function and dysfunction of the presenilins
4. Neuronal localisation of presenilin-1 and association with amyloid plaques and neurofibrillary tangles in Alzheimer's disease
5. Hyperaccumulation of FAD-linked presenilin 1 variants in vivo
6. Presenilin-1 protein expression in familial and sporadic Alzheimer's disease
7. Identification and neuron specific expression of the S182/presenilin 1 protein in human and rodent brains
8. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo
9. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice
10. 42(43) in brains of mice expressing mutant presenilin
11. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
12. Enhanced production and oligomerization of the 42-residue amyloid β-protein by Chinese hamster ovary cells stably expressing mutant presenilins
13. rd) residue
14. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
15. High levels of amyloid-beta protein from S182 (Glu246) familial Alzheimer's cells
16. 42(43)
17. 42 deposition and severe cerebellar pathology
18. 42(43)-plaque deposition in early-onset familial Alzheimer's disease brains with the deletion of exon 9 and the missense point mutation (H163R) in the PS-1 gene
19. A novel presenilin-1 mutation increases β-amyloid and neurofibrillary changes
20. A presenilin-1 Thr116Asn substitution in a family with early onset Alzheimer's disease
21. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity
22. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
23. Presenilin-1 is linked to γ-secretase activity in the detergent solubilized state
24. Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1
25. Peptidomimetic probes and molecular modelling suggests that Alzheimer's γ-secretase is an intramembrane-cleaving aspartyl protease
26. 1-42(43)
27. 40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele
28. 299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue
29. Aβ peptide length and apolipoprotein E genotype in Alzheimer's disease
30. Enhancement of amyloid β 42 secretion by 28 different presenilin 1 mutations of familial Alzheimer's disease
31. Early-onset Alzheimer's disease in 2 large Belgian families
32. Chromosome 14-encoded Alzheimer's disease: Genetic and clinicopathological description
33. Atypical amyloid (Aβ) deposition in the cerebellum in Alzheimer's disease: An immunohistochemical study using end-specific Aβ monoclonal antibodies
34. Phenotype of chromosome 14-linked familial Alzheimer's disease in a large kindred
35. Amyloid plaques in the cerebellum in Alzheimer's disease
36. The distribution of amyloid plaques in the cerebellum and brain stem in Down's syndrome and Alzheimer's disease: A light microscopical analysis
37. The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease
38. Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease
39. βA4 amyloid protein deposition in the cerebellum in Alzheimer's disease and Down's syndrome
40. The time course of pathological events concerned with plaque formation in Down's syndrome with particular reference to the involvement of microglial cells
41. 42(43)
42. 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene
43. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1
44. Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype
45. Identification of a mutation in Alzheimer's disease which destroys a splice acceptor site in the presenilin-1 gene
46. Alzheimer disease PS-1 exon 9 deletion defined
47. Splicing mutation of presenilin 1 gene for early-onset familial Alzheimer's disease
48. Variant Alzheimer's disease with spastic paraparesis. Clinical characterisation
49. Cases of Afzheimer's disease due to deletion of exon 9 of the presenilin-1 gene show an unusual but characteristic β amyloid pathology known as "cotton wool" plaques
50. APOE genetype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease
51. Amyloid, the presenilins and Alzheimer's disease
52. Notch is expressed in adult brain, and is coexpressed with presenilin-1 and is altered in Alzheimer's disease
53. Presenilin-1 differentially facilitates endoproteolysis of beta-amyloid and Notch
54. Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1
55. Proto-oncogene of int-3, a mouse Notch homologue, is expressed in endothelial cells during early embryogenesis
56. D114, a Notch ligand expressed in arterial endothelium
57. Notch signalling is essential for vascular morphogenesis in mice
58. Hereditary vascular dementia linked to Notch 3 mutations. CADASIL
59. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families
60. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
61. The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex
62. Direct association of presenilin-1 with beta-catenin
63. The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains β-catenin
64. Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis
65. Presenilin 1 interaction in the brain with a novel member of the Armadillo family
66. Presenilin-1 mutations in Alzheimer's disease